Impact of a modified data capture period on Liu comorbidity index scores in Medicare enrollees initiating chronic dialysis

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Rigler, Sally K ^a,b   Wetmore, James B ^a   Mahnken, Jonathan D ^a   Dong, Lei ^a   Ellerbeck, Edward F ^a   Shireman, Theresa I ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Chronic; Comorbidity; Epidemiologic research design; Kidney failure; Renal dialysis

Indexed keywords

ADULT; AGED; ARTICLE; BILLING AND CLAIMS; CALCULATION; CEREBROVASCULAR DISEASE; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; HEALTH CARE PLANNING; HEART FAILURE; HUMAN; KIDNEY FAILURE; LIU COMORBIDITY INDEX; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; MEDICAID; MEDICARE; MORTALITY; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; RATING SCALE; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SAMPLE SIZE; SCORING SYSTEM; TREATMENT DURATION;

BIAS (EPIDEMIOLOGY); COMORBIDITY; FEMALE; HUMANS; MALE; MEDICARE; MIDDLE AGED; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SAMPLE SIZE; SURVIVAL ANALYSIS; SURVIVAL RATE; UNITED STATES;

EID: 84874274925     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-51     Document Type: Article

References (27)

1. Observational versus experimental studies: what's the evidence for a hierarchy? Concato J, NeuroRx: J Am Soc Exp Neurother 2004 1 341 347 (Pubitemid 46621060)
2. Is it time for medicine-based evidence? Concato J, JAMA 2012 307 1641 1643 10.1001/jama.2012.482 22511693
3. Observational methods in comparative effectiveness research. Concato J, Lawler EV, Lew RA, Gaziano JM, Aslan M, Huang GD, Am J Med 2010 123 12 Suppl 1 16 e23 21184862
4. The number, quality, and coverage of randomized controlled trials in nephrology. Strippoli GF, Craig JC, Schena FP, J Am Soc Nephrol 2004 15 411 419 10.1097/01.ASN.0000100125.21491.46 14747388 (Pubitemid 38140782)
5. The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Charytan D, Kuntz RE, Kidney Int 2006 70 2021 2030 17051142 (Pubitemid 44863392)
6. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Uhlig K, Macleod A, Craig J, Kidney Int 2006 70 2058 2065 17003817 (Pubitemid 44871367)
7. Grading evidence-based guidelines-what are the issues? Uhlig K, Balk EM, Lau J, Am J Kidney Dis 2008 52 211 215 10.1053/j.ajkd.2008.06.002 18640485 (Pubitemid 351982030)
8. Underrepresentation of renal disease in randomized controlled trials of cardiovascular disease. Coca SG, Krumholz HM, Garg AX, Parikh CR, JAMA 2006 296 1377 1384 10.1001/jama.296.11.1377 16985230 (Pubitemid 44427424)
9. Survivor treatment bias, treatment selection bias, and propensity scores in observational research. Austin PC, Platt RW, J Clin Epidemiol 2010 63 136 138 10.1016/j.jclinepi.2009.05.009 20122500
10. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ, Am J Epidemiol 2001 154 854 864 10.1093/aje/154.9. 854 11682368 (Pubitemid 33000813)
11. Use of comorbidity scores for control of confounding in studies using administrative databases. Schneeweiss S, Maclure M, Int J Epidemiol 2000 29 891 898 10.1093/ije/29.5.891 11034974
12. Secular trends in cardiovascular mortality rates of patients receiving dialysis compared with the general population. Roberts MA, Polkinghorne KR, McDonald SP, Ierino FL, Am J Kidney Dis 2011 58 64 72 10.1053/j.ajkd.2011.01.024 21458896
13. Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased? Stenvinkel P, Barany P, Nature Rev Nephrol 2012 8 72 74
14. Confounding effect of comorbidity in survival studies in patients on renal replacement therapy. van Manen JG, van Dijk PC, Stel VS, Nephrol Dial Transplant 2007 22 187 195 16998216 (Pubitemid 46050344)
15. Comorbidity and confounding in end-stage renal disease. Seliger SL, Kidney Int 2010 77 83 85 10.1038/ki.2009.431 20040920
16. U.S. Renal Data System 2010 Annual Data Report, Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD 2011 http://www.usrds.org/adr.aspx
17. An improved comorbidity index for outcome analyses among dialysis patients. Liu J, Huang Z, Gilbertson DT, Foley RN, Collins AJ, Kidney Int 2010 77 141 151 10.1038/ki.2009.413 19907414
18. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Plantinga LC, Fink NE, Levin NW, Am J Kidney Dis 2007 49 831 840 10.1053/j.ajkd.2007.03.017 17533026 (Pubitemid 46802937)
19. Association of race with cumulative exposure to statins in dialysis. Wetmore JB, Mahnken JD, Rigler SK, Am J Nephrol 2012 36 90 96 10.1159/000339626 22739257
20. Cassella G, Berger RL, Statistical Inference Pacific Grove, CA: Duxbury Press 2 2002
21. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Charlson ME, Pompei P, Ales KL, MacKenzie CR, J Chronic Dis 1987 40 373 383 10.1016/0021-9681(87)90171-8 3558716 (Pubitemid 17055592)
22. Adapting the Charlson Comorbidity Index for use in patients with ESRD. Hemmelgarn BR, Manns BJ, Quan H, Ghali WA, Am J Kidney Dis 2003 42 125 132 10.1016/S0272-6386(03)00415-3 12830464 (Pubitemid 36807661)
23. How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT, Am J Kidney Dis 2002 40 82 89 10.1053/ajkd.2002.33916 12087565 (Pubitemid 34701215)
24. Adjustment for comorbidity in studies on health status in ESRD patients: which comorbidity index to use? Van Manen JG, Korevaar JC, Dekker FW, Boeschoten EW, Bossuyt PM, Krediet RT, J Am Soc Nephrol 2003 14 478 485 10.1097/01.ASN.0000043902.30577.C9 12538750 (Pubitemid 36150873)
25. Comorbidity and its change predict survival in incident dialysis patients. Miskulin DC, Meyer KB, Martin AA, Am J Kidney Dis 2003 41 149 161 10.1053/ajkd.2003.50034 12500232 (Pubitemid 36043362)
26. Considering health insurance: how do dialysis initiates with Medicaid coverage differ from persons without Medicaid coverage? Wetmore JB, Rigler SK, Mahnken JD, Mukhopadhyay P, Shireman TI, Nephrol Dialysis Transplant 2010 25 198 205 10.1093/ndt/gfp396
27. In search of the perfect comorbidity measure for use with administrative claims data: does it exist? Baldwin LM, Klabunde CN, Green P, Barlow W, Wright G, Med Care 2006 44 745 753 10.1097/01.mlr.0000223475.70440.07 16862036 (Pubitemid 44284265)